Menu
GeneBe

SPO11

SPO11 initiator of meiotic double stranded breaks

Basic information

Region (hg38): 20:57329802-57343994

Links

ENSG00000054796NCBI:23626OMIM:605114HGNC:11250Uniprot:Q9Y5K1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPO11 gene.

  • Inborn genetic diseases (11 variants)
  • not provided (1 variants)
  • Non-obstructive azoospermia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPO11 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
11
clinvar
1
clinvar
12
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 11 0 1

Highest pathogenic variant AF is 0.0000265

Variants in SPO11

This is a list of pathogenic ClinVar variants found in the SPO11 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-57329907-G-C not specified Uncertain significance (Jul 19, 2023)2613262
20-57329968-C-A not specified Uncertain significance (Jan 26, 2022)2272916
20-57329973-A-G Benign (Jun 10, 2018)785662
20-57329974-C-T not specified Uncertain significance (Aug 21, 2023)2620041
20-57331866-C-G not specified Uncertain significance (Jan 16, 2024)3169256
20-57331891-A-G not specified Uncertain significance (Nov 13, 2023)3169257
20-57333992-T-C not specified Uncertain significance (Jan 05, 2022)2228720
20-57333995-A-G not specified Uncertain significance (Jun 07, 2023)2558859
20-57334006-A-G not specified Uncertain significance (Oct 03, 2022)2315892
20-57334033-G-A not specified Uncertain significance (Sep 16, 2021)2367004
20-57334831-G-A not specified Uncertain significance (Feb 15, 2023)2471567
20-57335807-C-T not specified Uncertain significance (Sep 16, 2021)2345537
20-57335907-G-A Non-obstructive azoospermia Likely pathogenic (Aug 23, 2021)1244233
20-57338301-C-A not specified Uncertain significance (Aug 12, 2021)2383565
20-57342817-T-C not specified Uncertain significance (Jan 24, 2023)2478607

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPO11protein_codingprotein_codingENST00000371263 1314236
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.45e-80.6051256870611257480.000243
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9751652040.8080.000009912595
Missense in Polyphen3651.9980.69233674
Synonymous-0.8017970.51.120.00000355728
Loss of Function1.171520.80.7229.28e-7282

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003950.000390
Ashkenazi Jewish0.000.00
East Asian0.0001160.000109
Finnish0.00009290.0000924
European (Non-Finnish)0.0004040.000396
Middle Eastern0.0001160.000109
South Asian0.00003640.0000327
Other0.0001670.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of a topoisomerase 6 complex specifically required for meiotic recombination. Together with TOP6BL, mediates DNA cleavage that forms the double-strand breaks (DSB) that initiate meiotic recombination. The complex promotes relaxation of negative and positive supercoiled DNA and DNA decatenation through cleavage and ligation cycles. Essential for the phosphorylation of SMC3, HORMAD1 and HORMAD2. {ECO:0000250|UniProtKB:Q9WTK8}.;
Pathway
Reproduction;Meiotic recombination;Meiosis;Cell Cycle (Consensus)

Recessive Scores

pRec
0.164

Intolerance Scores

loftool
0.908
rvis_EVS
0.46
rvis_percentile_EVS
78.46

Haploinsufficiency Scores

pHI
0.283
hipred
Y
hipred_score
0.585
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0848

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Spo11
Phenotype
hearing/vestibular/ear phenotype; immune system phenotype; endocrine/exocrine gland phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Gene ontology

Biological process
meiotic DNA double-strand break processing;DNA catabolic process, endonucleolytic;ovarian follicle development;synaptonemal complex assembly;reciprocal meiotic recombination;male meiosis I;spermatogenesis;spermatid development;female gamete generation;protein localization to chromosome;meiotic DNA double-strand break formation;meiotic telomere clustering;oogenesis;double-strand break repair involved in meiotic recombination
Cellular component
chromosome, telomeric region
Molecular function
DNA binding;DNA topoisomerase type II (ATP-hydrolyzing) activity;protein binding;ATP binding;endodeoxyribonuclease activity, producing 3'-phosphomonoesters;metal ion binding